I’m keeping an eye on RMD shares in 2026
raskmedia.com.au · 2026-10-09
The Resmed CDI (ASX:RMD) share price and QBE Insurance Group Ltd (ASX:QBE) share price are in focus in 2026. Here's how you could put a value on them.
TickrTrends take: ResMed Inc operates in the Healthcare sector and currently carries an Undervalued designation according to TickrTrends valuation analysis. Investors focused on valuation metrics should monitor whether RMD's fundamentals in 2026 will support or challenge this undervalued positioning, particularly given the Healthcare sector's sensitivity to regulatory and reimbursement changes. The gap between current valuation and intrinsic value represents the key variable that could either validate the undervalued thesis or signal a rerating as the year progresses.
Read the full story at raskmedia.com.au →
Is RMD undervalued? See TickrTrends' fair value analysis →